Biofilm-mediated immune dysregulation in chronic pulmonary diseases: mechanisms and clinical implications
Frontiers in Microbiology · 12.01.2026 · 16
DOI: 10.3389/fmicb.2025.1736384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.01.2026. Verfasst von Xiao Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, …. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Microbial biofilms are increasingly recognized as critical modulators of chronic airway inflammation and immune dysregulation in pulmonary diseases. This review summarizes current evidence on how biofilm formation and persistence alter host immune responses, contributing to the pathogenesis of chronic lung disorders. We first outline the characteristics of respiratory biofilms and the major pathogens involved. We then discuss how biofilms reshape innate and adaptive immunity—impairing pattern recognition receptor signaling, promoting neutrophil extracellular trap (NET) formation, altering macrophage polarization, and skewing T-cell differentiation. These immune alterations sustain low-grade inflammation, tissue remodeling, and immune tolerance, driving disease progression in chronic obstructive pulmonary disease, bronchiectasis, severe asthma, and even lung cancer. We further highlight emerging diagnostic biomarkers and therapeutic approaches targeting biofilm-associated immune pathways, including combined antibiofilm and immunomodulatory strategies. Finally, we identify key knowledge gaps and propose future research directions, emphasizing multi-omics approaches and personalized interventions to better define and target biofilm-driven immune dysregulation in chronic respiratory diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Internal Medicine V-Pulmonology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital, Homburg, Germany.
- Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, China.
- Department of Laboratory Medicine, Affiliated Lianyungang Clinical College of Nantong University, Lianyungang, Jiangsu, China.
Zitieren
APA
Yu, X., Zhang, Y., Yao, Y., Cho, W. C., & Shang, A. (2026). Biofilm-mediated immune dysregulation in chronic pulmonary diseases: mechanisms and clinical implications. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1736384
Vancouver
Yu X, Zhang Y, Yao Y, Cho WC, Shang A. Biofilm-mediated immune dysregulation in chronic pulmonary diseases: mechanisms and clinical implications. Frontiers in Microbiology. 2026;16. doi:10.3389/fmicb.2025.1736384
BibTeX
@article{Yu2026,
author = {Yu, Xiao and Zhang, Yidan and Yao, Yiwen and Cho, William C and Shang, Anquan},
title = {Biofilm-mediated immune dysregulation in chronic pulmonary diseases: mechanisms and clinical implications},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fmicb.2025.1736384}
}
EUVIMED